Preview: Travere Therapeutics's Earnings
Portfolio Pulse from Benzinga Insights
Travere Therapeutics (NASDAQ:TVTX) is set to release its latest quarterly earnings report on November 7, 2023. Analysts estimate an EPS of $-0.05. The company's past performance shows a pattern of beating EPS estimates but this has not always led to a positive impact on the share price. The stock is currently trading at $6.97, down 68.35% over the last 52-week period.
November 06, 2023 | 4:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Travere Therapeutics is expected to report an EPS of $-0.05. Despite past EPS beats, the stock price has not consistently increased. The stock is down 68.35% over the last year.
Travere Therapeutics has a history of beating EPS estimates, but this has not always resulted in a positive impact on the share price. Given the stock's negative performance over the past year, investors may be cautious.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100